Bodiongan, Claire .
HRN: 19-36-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2024
CEFUROXIME 500MG (TAB)
05/16/2024
05/23/2024
PO
500 Mg
BID
S/P NSVD With RMLE; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes